AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Q/C Technologies, Inc. Common Stock
XNAS · usd
SIC 2835 · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
FIGI BBG001SFSSG4
0.47▼ 0.06 (-10.74%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
—
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
0.53
Day's Range
0.45 – 0.54
52-Week Range
0.42 – 8.17
Volume
140.1K
Avg Volume
10.2M
Share Statistics
Shares Outstanding
Employees
2
Exchange
XNAS
Listed
2021-04-19
Share count as of August 12, 2026

Q/C Technologies, Inc. Common Stock (QCLS) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Q/C Technologies, Inc. Common Stock (QCLS)
What is Q/C Technologies, Inc. Common Stock's Market Cap?
Q/C Technologies, Inc. Common Stock's Market Cap is $3.9M, based on as-reported figures from SEC (XBRL) filings.
What is Q/C Technologies, Inc. Common Stock's Enterprise Value?
Q/C Technologies, Inc. Common Stock's Enterprise Value is -$7.1M, based on as-reported figures from SEC (XBRL) filings.
What is Q/C Technologies, Inc. Common Stock's Revenue (TTM)?
Q/C Technologies, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Q/C Technologies, Inc. Common Stock's Net Income (TTM)?
Q/C Technologies, Inc. Common Stock's Net Income (TTM) is -$18.3M, based on as-reported figures from SEC (XBRL) filings.
What is Q/C Technologies, Inc. Common Stock's Diluted EPS (TTM)?
Q/C Technologies, Inc. Common Stock's Diluted EPS (TTM) is -2.24, based on as-reported figures from SEC (XBRL) filings.
What is Q/C Technologies, Inc. Common Stock's Net Debt?
Q/C Technologies, Inc. Common Stock's Net Debt is -$11.0M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · QCLSAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue———
Cost of Revenue———
Gross Profit———
% of revenue———
Selling, General and Administrative Expense
Research and Development Expense
Stock-Based Compensation Expense
Franchise Tax Expense—
Amortization of Intangibles——
Loss from Operations
% of revenue———
Other (Income) Expenses
Interest and Dividend Income
Gain on Sale of Investments——
Change in fair value of Marketable Securities—
Change in fair value of Derivatives Liabilities
Total Other (Income)/Expense
Loss Before Income Tax
Net Loss
% of revenue———
Preferred Dividends
Net Loss Attributable to Common Stockholders
Earnings Per Share (Basic)—
Earnings Per Share (Diluted)—